NKCF News Keratoconus Around the World: Athens Protocol 3 years ago Keratoconus Around the World: Athens Protocol Corneal crosslinking (CXL) has become the gold standard for halting progression of keratoconus. The… Heart Condition Associated with KC 3 years ago Forty years ago, the first article was published reporting that individuals with keratoconus (KC) appeared to have a higher-than-average incidence… Walking in Sunshine 3 years ago During early clinical trials for cornea crosslinking (CXL), ophthalmologist Dr. John Jarstand MD of Evergreen Eye Center in Washington met a… Blepharitis: why eyelids get red & itchy 3 years ago Regretfully, many individuals with keratoconus also suffer from other conditions affecting the health and comfort of their eyes. Dry eye… May 2021 Update Newsletter 3 years ago Click here to read the May 2021 NKCF Newsletter What Happens After CXL? Results from an NKCF Update Survey 3 years ago In the February NKCF Update, we asked those who had corneal crosslinking (CXL) about their experience. Seventeen people responded. We thank… TOP DOCS of 2021 4 years ago TOP DOCS OF 2021 NKCF Update readers submitted stories about their doctor as part of our annual celebration honoring eye… New Artificial Cornea in Clinical Trials 4 years ago CorNeat Vision, a medical device company based in Israel is conducting a clinical trial to test the safety and efficacy… Corneal Transplant Patients & COVID-19 4 years ago FAQs about Crosslinking 4 years ago NKCF has compiled a list of commonly asked questions regarding corneal crosslinking (CXL). Visit the Answering Your Questions about Crosslinking page… Next» « Previous